Cirqle Biomedical Contraception ApS: Financial statements 2025
CVR: 39865769
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Cirqle Biomedical Contraception ApS (CVR 39865769) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -2,426,548 and a net result of DKK -6,409,656 compared with DKK 43,425,442 the year before. Equity in the 2025 report amounted to DKK 29,520,931. The solvency ratio was 93.8%. The company had 4 employees in the financial year.
- Gross Profit
- DKK -2,426,548
- Profit/Loss
- DKK -6,409,656
- Equity
- DKK 29,520,931
- Total Assets
- DKK 31,468,306
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -2.4 mio. | -6.4 mio. | 29.5 mio. | 4 |
| 2024 | - | 60.6 mio. | 43.4 mio. | 35.9 mio. | 7 |
| 2023 | - | -12.8 mio. | -16 mio. | 34.4 mio. | 9 |
| 2022 | - | 62.1 mio. | 47.7 mio. | 50.4 mio. | 5 |
| 2021 | - | -5.8 mio. | -7.2 mio. | -4.4 mio. | 5 |
Official annual report
How creditworthy is Cirqle Biomedical Contraception ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Cirqle Biomedical Contraception ApS has published its annual report for 2024. Gross profit came to DKK 60,578,876, and the net result was DKK 43,425,442.
About Cirqle Biomedical Contraception ApS
Cirqle Biomedical Contraception ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Cirqle Biomedical Contraception IVS and Circle Biomedical Contraception IVS. The management consists of Frederik Petursson Madsen and Thomas Crouzier. The board consists of Jesper Boysen (chair), Frederik Petursson Madsen and Thomas Crouzier. The company is owned by Cirqle Biomedical Holding ApS and RH CAPITAL FUND II, LP. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK -2,426,548 and a net result of DKK -6,409,656 compared with DKK 43,425,442 the year before. Equity in the 2025 report amounted to DKK 29,520,931.